acrolein has been researched along with Infections, Respiratory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freed, BM; Harvey, J; Jonscher, K; Lambert, C; Li, J; Quintana, M; Reigan, P; Yang, TC | 1 |
| Didry, N; Dubreuil, L; Pinkas, M | 1 |
2 other study(ies) available for acrolein and Infections, Respiratory
| Article | Year |
|---|---|
Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain.
Topics: Acrolein; Aldehydes; Arginine; Cells, Cultured; Cysteine; Cytokines; DNA; Gene Expression Regulation; Humans; Lung; NF-kappa B p50 Subunit; NFATC Transcription Factors; Nicotiana; Protein Binding; Respiratory Tract Infections; Smoke; T-Lymphocytes; Transcription Factor AP-1 | 2007 |
[Antibacterial activity of thymol, carvacrol and cinnamaldehyde alone or in combination].
Topics: Acrolein; Bacteria; Cymenes; Drug Combinations; Humans; Microbial Sensitivity Tests; Monoterpenes; Respiratory Tract Infections; Terpenes; Thymol | 1993 |